176 citations
,
May 2020 in “Dermatologic Therapy” This review discusses the cutaneous symptoms associated with COVID-19 and their potential use in diagnosing and assessing the severity of the disease, but it reports no new clinical results.
26 citations
,
January 2020 in “Dermatology Online Journal” This study found that livedoid and acro-ischemic skin manifestations were significantly associated with severe COVID-19, while chilblains-like eruptions appeared in less severe cases.
1 citations
,
August 2020 in “Open Access Macedonian Journal of Medical Sciences” This review summarizes current knowledge on cutaneous symptoms in COVID-19, emphasizing their potential prognostic and therapeutic implications, but reports no new clinical findings.
May 2024 in “International Journal of Advanced Multidisciplinary Research and Studies” In this cross-sectional study of COVID-19 positive patients in Bangladesh, researchers found that maculo-papular eruptions were the most common dermatological manifestation, with other prevalent conditions including chilblain-like eruptions, urticarial lesions, and petechiae/purpura.
August 2021 in “Journal of skin and stem cell” Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.